BOSTON ONCOLOGY ARABIA

About BOSTON ONCOLOGY ARABIA

Boston Oncology is an innovative biogenerics company focused on redefining excellence in the licensing, local development, manufacturing, and distribution of US-quality medicines across various therapeutic areas. Headquartered in Cambridge, Massachusetts, with principal offices and a world-class manufacturing center in Saudi Arabia, the company is committed to providing high-quality healthcare regardless of wealth, status, or geography, aligning with global standards and local manufacturing.

Products & Services

US-Quality Biogenerics:Class-leading biogenerics licensed from USFDA/EMA registered sources, ensuring high quality.

Manufacturing Facilities:Modular and flexible manufacturing facilities, including a GMP-certified center in Saudi Arabia with an annual vial capacity of over 30 million units.

Customer-Centered Procurement:Single-point-of-contact procurement for streamlined and efficient service delivery.

Specialties

Biogenerics Licensing and Development Local Manufacturing of Pharmaceuticals Global Supply Chain Management Quality Assurance and Speed to Market

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Growth Capital Investment T: - FT: Growth Capital Investment	A: 35000000 MR: - FA: USD 35 million FAN: 35000000	D: 2024-06-26 FD: 2024-06-26	2 investors

Growth Capital Investment Latest

2024-06-26

$35.0M

2 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News